OPEN Journal of the American College of Cardiology | 18 Feb 2017
MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, JL Halperin, CS Ma, K Zint, A Elsaesser, DB Bartels and GY Lip
GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non-vitamin K antagonist oral anticoagulant (NOAC), became available.
* Data courtesy of Altmetric.com